MC0704 is a STAT3 Inhibitor for Triple-negative Breast Cancer
triple-negative breast cancer MedChemExpress (MCE) Life Science
Selective inhibitory activity of 9l towards H3K79 methylation in
NU6102 is a Potent CDK1 and CDK2 Inhibitor
A novel small molecule STAT3 inhibitor SLSI-1216 suppresses
Arnicolide D Inhibits Triple Negative Breast Cancer Cell
Relationship between signal transducer and activator of
A 83-01 is a Potent Inhibitor of TGF-β Type I Receptor ALK5 Kinase
A novel small molecule STAT3 inhibitor SLSI-1216 suppresses
A novel small molecule STAT3 inhibitor SLSI-1216 suppresses
Targeting regulated cell death (RCD) with small-molecule compounds
PDF) Antitumor Activity of Pulvomycin via Targeting Activated
Arnicolide D Inhibits Triple Negative Breast Cancer Cell
NG25, a Dual Inhibitor of TAK1 and MAP4K2, Enhances Doxorubicin-mediated Apoptosis in Breast Cancer
The novel STAT3 inhibitor WZ-2-033 causes regression of human
